BMF |
BMF: Bcl-2-modifying factor |
MAPK7 |
MAPK7, ERK4, ERK5, PRKM7: Mitogen-activated protein kinase 7 |
4.685 |
Evidence |
|
PDPK1 |
PDPK1, PDK1: 3-phosphoinositide-dependent protein kinase 1 |
TPH1 |
IPI00654547 |
4.685 |
Evidence |
|
BCR |
BCR, BCR1, D22S11: Breakpoint cluster region protein |
SH2D2A |
SH2D2A, SCAP, TSAD, VRAP: SH2 domain-containing protein 2A |
4.685 |
Evidence |
|
PTK6 |
PTK6, BRK: Tyrosine-protein kinase 6 |
PPP1R14C |
PPP1R14C, KEPI: Protein phosphatase 1 regulatory subunit 14C |
4.685 |
Evidence |
|
SGK |
SGK, SGK1: Serine/threonine-protein kinase Sgk1 |
EVL |
EVL, RNB6: Ena/VASP-like protein |
4.685 |
Evidence |
|
FYN |
FYN: Proto-oncogene tyrosine-protein kinase Fyn |
C9orf88 |
IPI00456750 |
4.685 |
Evidence |
|
PTPN6 |
PTPN6, HCP, PTP1C: Tyrosine-protein phosphatase non-receptor type 6 |
GRB10 |
IPI00012752 |
4.685 |
Evidence |
|
BTK |
BTK, AGMX1, ATK, BPK: Tyrosine-protein kinase BTK |
IGHE |
IGHE: Ig epsilon chain C region |
4.685 |
Evidence |
|
IGHA1 |
IPI00719411 |
LCK |
LCK: Proto-oncogene tyrosine-protein kinase LCK |
4.685 |
Evidence |
|
CDH2 |
CDH2, CDHN, NCAD: Cadherin-2 precursor |
PCDH1 |
PCDH1: Protocadherin-1 precursor |
4.685 |
Evidence |
|
CRK |
CRK: Proto-oncogene C-crk |
SLA2 |
SLA2, C20orf156, SLAP2: Src-like-adapter 2 |
4.685 |
Evidence |
|
JAK2 |
JAK2: Tyrosine-protein kinase JAK2 |
IGHE |
IGHE: Ig epsilon chain C region |
4.685 |
Evidence |
|
PECAM1 |
PECAM1: Platelet endothelial cell adhesion molecule precursor |
GRB10 |
IPI00012752 |
4.685 |
Evidence |
|
TXK |
TXK, PTK4: Tyrosine-protein kinase TXK |
GSK3B |
GSK3B: Glycogen synthase kinase-3 beta |
4.685 |
Evidence |
|
KLK6 |
KLK6, PRSS18, PRSS9: Kallikrein-6 precursor |
LTBP1 |
LTBP1: Latent-transforming growth factor beta-binding protein, isoform 1S precur |
4.685 |
Evidence |
|
SOCS3 |
SOCS3, CIS3, SSI3: Suppressor of cytokine signaling 3 |
GRB10 |
IPI00012752 |
4.685 |
Evidence |
|
C4B |
C4B: Complement C4-B precursor |
F5 |
F5: Coagulation factor V precursor |
4.685 |
Evidence |
|
GRB10 |
IPI00012752 |
FRS2 |
FRS2: Fibroblast growth factor receptor substrate 2 |
4.685 |
Evidence |
|
NTRK1 |
NTRK1, TRK: High affinity nerve growth factor receptor precursor |
CD3E |
CD3E, T3E: T-cell surface glycoprotein CD3 epsilon chain precursor |
4.685 |
Evidence |
|
VDAC1 |
VDAC1, VDAC: Voltage-dependent anion-selective channel protein 1 |
BMF |
BMF: Bcl-2-modifying factor |
4.685 |
Evidence |
|
CAV1 |
CAV1, CAV: Caveolin-1 |
ITK |
ITK, EMT, LYK: Tyrosine-protein kinase ITK/TSK |
4.685 |
Evidence |
|
NULL |
Ig heavy chain V-III region WEA |
LCP2 |
LCP2: Lymphocyte cytosolic protein 2 |
4.685 |
Evidence |
|
CTLA4 |
CTLA4, CD152: Cytotoxic T-lymphocyte protein 4 precursor |
PTK2B |
PTK2B, FAK2, PYK2, RAFTK: Protein tyrosine kinase 2 beta |
4.685 |
Evidence |
|
SYK |
SYK: Tyrosine-protein kinase SYK |
KIRREL |
KIRREL, KIRREL1, NEPH1: Kin of IRRE-like protein 1 precursor |
4.685 |
Evidence |
|
SIN3A |
SIN3A: Paired amphipathic helix protein Sin3a |
PRIC285 |
PRIC285, KIAA1769: Peroxisomal proliferator-activated receptor A-interacting com |
4.685 |
Evidence |
|